Op-Ed
Big changes are afoot in the way patent drugs are priced in Canada. At present, Canada’s Patented Medicine Prices Review Board (PMPRB), a federal agency, is responsible for setting maximum prices…
Intelligence Memos
From: Paul Jenkins
To: Canada’s Decision-Makers
Date: July 15, 2021
Subject: Early COVID Lessons: More Strategic Thinking and Less Noise
I have always believed a hallmark of Canada has been our…
Intelligence Memos
From: Bryan Thomas, Colleen M. Flood, Vivek Krishnamurthy, Ryan Tanner and Kumanan Wilson
To: Canadians Concerned about Vaccine Passports
Date: July 12, 2021
Re: Four Privacy…
